Sebia
Sebia, the global leader in clinical electrophoresis equipment and reagents, offers both capillary separation and agarose gel technologies. Following the acquisition of Orgentec in 2021 Sebia is expanding its core competencies to include autoimmunity testing. Sebia’s automated capillary electrophoresis portfolio, the CAPILLARYS 3 Family and MINICAP Flex Piercing systems, provide full walkaway capability and workload flexibility on our multi-assay instruments. Adding a tube loader with the CAPILLARYS 3 TERA allows for custom configuration of our MC family for added capacity and work cell productivity. Sebia platforms are driven by PHORESIS Core analysis and networking software.
For autoimmunity, Sebia offers the fully automated, random access Alegria 2 ELISA platform*; coupled with a comprehensive menu of antigen assays & panels utilizing a unique Monotest Strip Technology; allowing serum, plasma, and fecal sample testing in the same run. (* Not available in the US.)